Projects and programmes

Health Professional Co-Design of an Asthma Clinical Decision Support Tool

The ACRC is an interdisciplinary research collaboration, combining a complementary programme of research and development to deliver innovation and change to later life care.

A group of international researchers and clinicians with expertise in evidence synthesis across a range of vascular disorders, including heart disease, stroke, peripheral arterial disease, vascular dementia and hypertension.

AIM-CISC is a research programme that aims to produce a detailed picture of multiple long-term health conditions (MLTCs) in the UK, and use the results of this research to inform future strategies in dealing with this issue.

A new collaborative consortium for the study of pregnancy treatments.

Generating evidence to support policy and practice to address tobacco use during and beyond the Covid-19 pandemic.

The COVID-19 in Pregnancy in Scotland (COPS) study aims to find out how COVID-19 infection during pregnancy affects mothers and babies.

National Core Studies - Data and Connectivity: COVID-19 Vaccines Pharmacovigilance

Awarded through a funding call by Health Data Research UK and the Alan Turing Institute, and led by Professor Aziz Sheikh, this project works to use UK-wide data to study the uptake, safety and effectiveness of COVID-19 vaccines.

Drugs and Alcohol Service users Help to Exit Smoking

Developing and validating a risk prediction model for Long COVID using the EAVE II study in Scotland.

The aim is to develop a co-created, evidence based vaping prevention programme to be delivered in the secondary schools setting.

Tracking the COVID-19 pandemic as it happens across Scotland.

Could a simple salt water solution help to reduce the early symptoms and progression of COVID-19?

Development and evaluation of a complex ePrescribing-based Antimicrobial Stewardship (ePAMS+) intervention for hospitals.

Formative and summative evaluations of the Global Digital Exemplar (GDE) Programme.

The project tracks the deployment of stroke AI across Scotland over two years with the aim to establish the effects of AI on practices (e.g., stroke diagnosis and triage), stroke practitioners (e.g., clinicians’ roles and skills), and the Scottish healthcare system (e.g., stroke care pathways).

IHDP seeks to fundamentally change the way data and analytics are used to drive improvement in health outcomes, by fostering new relationships between the NHS, industry, academia, and the third sector.

Independent mixed-methods evaluation of the NHS AI Lab

PRoGRAM-A is peer-led, social network intervention to protect young people, their friends and family members from gambling related harm.

The RESCEU project aims to develop robust evidence on respiratory syncytial virus (RSV) disease burden and economic impact in Europe and provide infrastructure to perform future pivotal clinical trials for RSV vaccines and therapeutics.

Funded by the National Institute for Health Research, RESPIRE is a Global Health Research Unit focusing on respiratory health in Asia.

Investigating the uptake, safety, and effectiveness of monoclonal antibody therapy for COVID-19, using EAVE II linked data, working with Public Health Scotland (PHS).

We are a multi-university, multi-agency research consortium focused on the commercial determinants of health and health inequalities funded by the UK Prevention Research Partnership.

Improving research capacity in Low and Middle Income Countries to conduct high quality studies that will generate evidence on how to reduce morbidity and mortality caused by tobacco use, and to advance key development priorities.

Using the EAVE II cohort to investigate the effectiveness of currently administered or future approved vaccines by dose, viral variants and patient clinical and demographic characteristics.

Viral Memories explores how gay men used their experiences and memories of HIV (and the AIDS crisis) to navigate COVID-19, and how COVID-19 changed how we think of HIV.